Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

72.65

+1.45 (2.04%)

At close: Jun 3, 2026, 4:00 PM EDT

69.66

-2.99 (-4.12%)

After-hours: Jun 3, 2026, 7:40 PM EDT

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	7,799	3,688	5,297	3,359	2,190	2,098
Market Cap Growth	-2.04%	-30.38%	57.70%	53.35%	4.41%	-31.31%
Enterprise Value	7,293	3,320	4,919	2,990	1,758	1,874
Last Close Price	72.65	34.80	50.39	32.48	20.31	19.80
PE Ratio	180.72	42.44	40.97	34.55	23.34	22.25
Forward PE	62.67	55.53	32.11	32.61	19.95	21.01
PEG Ratio	-	-	-	-	-	1.50
PS Ratio	10.14	4.84	7.85	6.96	5.45	5.73
PB Ratio	12.22	5.69	7.79	6.63	4.36	5.58
P/TBV Ratio	13.22	6.45	8.41	7.16	4.69	6.64
P/FCF Ratio	64.91	26.01	27.01	26.54	18.26	12.53
P/OCF Ratio	64.75	25.97	26.71	26.51	18.20	12.49
EV/Sales Ratio	9.48	4.36	7.29	6.20	4.38	5.12
EV/EBITDA Ratio	-	72.27	35.71	27.61	15.44	14.88
EV/EBIT Ratio	-	74.12	35.92	27.87	15.61	15.06
EV/FCF Ratio	60.70	23.42	25.08	23.63	14.66	11.19
Debt / Equity Ratio	0.01	0.01	0.01	0	0	0
Debt / EBITDA Ratio	-	0.13	0.05	0.00	0.01	0.00
Debt / FCF Ratio	0.08	0.04	0.04	0.00	0.01	0.00
Net Debt / Equity Ratio	-0.51	-0.56	-0.55	-0.73	-0.86	-0.59
Net Debt / EBITDA Ratio	48.62	-7.97	-2.73	-3.40	-3.78	-1.77
Net Debt / FCF Ratio	-2.74	-2.58	-1.92	-2.91	-3.59	-1.33
Asset Turnover	0.93	0.91	0.92	0.80	0.80	0.74
Inventory Turnover	1.04	1.03	1.08	0.94	0.97	1.07
Quick Ratio	2.53	2.60	3.11	4.05	6.58	5.28
Current Ratio	2.86	2.92	3.35	4.39	6.89	5.60
Return on Equity (ROE)	7.36%	15.01%	23.81%	21.05%	23.11%	25.03%
Return on Assets (ROA)	-3.89%	8.01%	16.38%	15.17%	19.52%	22.51%
Return on Invested Capital (ROIC)	-8.64%	18.60%	44.95%	73.62%	80.87%	88.53%
Return on Capital Employed (ROCE)	-1.23%	6.54%	22.51%	20.87%	25.39%	27.65%
Earnings Yield	0.60%	2.36%	2.44%	2.89%	4.28%	4.49%
FCF Yield	1.54%	3.84%	3.70%	3.77%	5.48%	7.98%
Buyback Yield / Dilution	-0.16%	-5.73%	-1.56%	3.64%	7.94%	-1.42%
Total Shareholder Return	-0.16%	-5.73%	-1.56%	3.64%	7.94%	-1.42%

SEC Filings: 10-K · 10-Q